Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 Apr 11:3:80.
doi: 10.3389/fonc.2013.00080. eCollection 2013.

Application of FDG-PET/CT in Radiation Oncology

Jun Li  1 , Ying Xiao
Affiliations

Application of FDG-PET/CT in Radiation Oncology

Jun Li et al. Front Oncol. .

Abstract

Positron emission tomography (PET)/computed tomography (CT), which combines the advantages of high sensitivity and specificity of PET and high resolution of CT, is a unique tool for cancer management. PET/CT has been widely used in cancer diagnosis and treatment. The article reviews the recent applications of PET/CT in radiation oncology, with a focus on (18)F-fluorodeoxyglucose (FDG)-PET/CT, addressing the applications in treatment planning and treatment response assessment of radiation therapy.

Keywords: PET/CT; radiation oncology; radiation therapy; treatment planning; treatment response.

PubMed Disclaimer

References

    1. Bettinardi V., Picchio M., Di Muzio N., Gilardi M. C. (2012). Motion management in positron emission tomography/computed tomography for radiation treatment planning. Semin. Nucl. Med. 42, 289–307 10.1053/j.semnuclmed.2012.04.001 - DOI - PubMed
    1. Borst G. R., Belderbos J. S., Boellaard R., Comans E. F., De Jaeger K., Lammertsma A. A., et al. (2005). Standardised FDG uptake: a prognostic factor for inoperable non-small cell lung cancer. Eur. J. Cancer 41, 1533–1541 10.1016/j.ejca.2005.03.026 - DOI - PubMed
    1. Bradley J. D., Perez C. A., Dehdashti F., Siegel B. A. (2004). Implementing biologic target volumes in radiation treatment planning for non-small cell lung cancer. J. Nucl. Med. 45(Suppl. 1), 96S–101S - PubMed
    1. Bussink J., Kaanders J. H., van der Graaf W. T., Oyen W. J. (2011). PET-CT for radiotherapy treatment planning and response monitoring in solid tumors. Nat. Rev. Clin. Oncol. 8, 233–242 10.1038/nrclinonc.2010.218 - DOI - PubMed
    1. Caldarella C., Salsano M., Isgrò M. A., Treglia G. (2012). The role of fluorine-18-fluorodeoxyglucose positron emission tomography in assessing the response to neoadjuvant treatment in patients with osteosarcoma. Int. J. Mol. Imaging 2012, 870301. - PMC - PubMed

LinkOut - more resources